SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

13 Aug 2025 Evaluate
The total revenue for the quarter ended June 2025 remained nearly unchanged at Rs. 341.22 millions.A humble growth in net profit of 18.23% reported in the quarter ended June 2025 to Rs. 47.93  millions from Rs. 40.54 millions.Operating Profit saw a handsome growth to 70.67 millions from 64.31 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 341.22 334.22 2.09 341.22 334.22 2.09 1815.87 1315.99 37.99
Other Income 34.95 32.12 8.81 34.95 32.12 8.81 137.15 61.89 121.60
PBIDT 70.67 64.31 9.89 70.67 64.31 9.89 445.53 265.06 68.09
Interest 5.87 4.90 19.80 5.87 4.90 19.80 21.26 19.08 11.43
PBDT 64.80 59.41 9.07 64.80 59.41 9.07 424.27 245.98 72.48
Depreciation 4.99 3.49 42.98 4.99 3.49 42.98 17.37 12.44 39.63
PBT 59.81 55.92 6.96 59.81 55.92 6.96 406.90 233.54 74.23
TAX 11.88 15.38 -22.76 11.88 15.38 -22.76 95.33 57.79 64.96
Deferred Tax -1.11 2.73 -140.66 -1.11 2.73 -140.66 -3.17 -5.86 -45.90
PAT 47.93 40.54 18.23 47.93 40.54 18.23 311.57 175.75 77.28
Equity 160.82 160.82 0.00 160.82 160.82 0.00 160.82 160.82 0.00
PBIDTM(%) 20.71 19.24 7.64 20.71 19.24 7.64 24.54 20.14 21.82

Kilitch Drugs(India) Share Price

135.10 4.55 (3.49%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×